Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and Topotecan vs Cisplatin and Topotecan in Recurrent Cervical Cancer
NCT01405235Phase 3Unknown
- Sponsor
- Institut Frauengesundheit
- Start
- Sep 2006
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel in Cervical Cancer (CC), sponsored by Institut Frauengesundheit. Status: unknown.
02
Drugs
paclitaxel
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT01405235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01405235.